Clinical Trials Logo
  1. Home
  2. Adolescent Depression
  3. NCT01170520

Repetitive Transcranial Stimulation (rTMS) for Resistant Depression in Adolescents

Adolescent Depression Clinical Trial

Official title:
The Addition of rTMS to the Therapy of Adolescents That Suffer From Treatment Resistant Depression: An Open Label Study

Clinical Trial Summary

The investigators hypothesis that repetitive transcranial Stimulation (rTMS) is a safe and effective add-on therapy for resistent depression in adolescent patients.

A group of adolescents suffering from non psychotic major depression that was resistant to at least 2 drug trials and a trail of psychotherapy will be recruited. After an informed consent procedure for both parents and patients, patients will go through a clinical and cognitive evaluation. They will receive a protocol of 4 weeks (20 work days) of rTMS using the figure of 8 magstim coil at 100% threshold, 42 trains of 4 seconds each, intertrain interval of 30 sec to the LDPC, 1680 pulses per day. Then they will be reevaluated.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01170520
Study type Interventional
Source Shalvata Mental Health Center
Contact Yuval Bloch, MD
Phone 972-506264628
Email yuvalbl@clalit.org.il; aviva100@bezeqint.net
Status Recruiting
Phase Phase 1/Phase 2
Start date August 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT00399776 - Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy N/A
Completed NCT04603053 - Determining Effectiveness of an mHealth Intervention to Provide Adolescent CBT N/A
Completed NCT01802437 - An Adaptive Treatment Strategy for Adolescent Depression Phase 1/Phase 2
Completed NCT06325605 - Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression N/A
Completed NCT02017535 - An Adaptive Treatment Strategy for Adolescent Depression-Continuation Phase 1/Phase 2
Completed NCT03154008 - Predictors of Response to Treatment for Depression N/A
Recruiting NCT04613453 - Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine Phase 2
Terminated NCT00284791 - Lamotrigine in Treatment Resistant Depression in Adolescents N/A
Completed NCT00312897 - Omega-3 Fatty Acids in Adolescent Depression Phase 2
Recruiting NCT01857518 - Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study N/A
Recruiting NCT06072677 - Adolescent Mood During Puberty and Testosterone N/A